| Literature DB >> 33619293 |
Magdalena Ciążyńska1, Grażyna Kamińska-Winciorek2, Dariusz Lange3, Bogumił Lewandowski4, Adam Reich5, Martyna Sławińska6, Marta Pabianek7, Katarzyna Szczepaniak7, Adam Hankiewicz7, Małgorzata Ułańska7, Jan Morawiec8, Maria Błasińska-Morawiec7, Zbigniew Morawiec8, Janusz Piekarski9, Dariusz Nejc9, Robert Brodowski4, Anna Zaryczańska6, Michał Sobjanek6, Roman J Nowicki6, Witold Owczarek10, Monika Słowińska10, Katarzyna Wróbel10, Andrzej Bieniek11, Anna Woźniacka12, Małgorzata Skibińska13, Joanna Narbutt13, Wojciech Niemczyk14, Karol Ciążyński15, Aleksandra Lesiak13.
Abstract
Non-melanoma skin cancers (NMSCs) are the most common malignancies diagnosed in Caucasian populations. Basal cell carcinoma (BCC) is the most frequent skin cancer, followed by squamous cell carcinoma (SCC). Unfortunately, most European cancer registries do not record individual types of NMSC. To evaluate the incidence of primary BCCs and SCCs regarding age, sex, tumour site and tumour subtype to determine trends in epidemiology of both cancers. Retrospective analysis of BCCs and SCCs diagnosed and treated across seven sites in Poland from 1999 to 2019. We recorded 13,913 NMSCs occurring in 10,083 patients. BCC represented 85.2% of all cases. SCC patients were older than BCC patients (77.1 ± 11.3 years vs. 70.1 ± 12.3 years, p < 0.01). The nodular subtype was the most common subtype of BCC, followed by the superficial and infiltrative subtypes. The superficial BCC subtype was more common on photoprotected areas (p < 0.01), whereas the nodular BCC subtype occurred on the face (p < 0.01). The high-risk SCC subtypes were more common on face compared to low-risk SCC subtypes (p < 0.01). BCC and SCC are common malignancies developing at various ages and anatomical sites. These data underline the need for better registration policies regarding NMSC in order to improve prevention and treatment strategies for these tumours.Entities:
Mesh:
Year: 2021 PMID: 33619293 PMCID: PMC7900109 DOI: 10.1038/s41598-021-83502-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379